These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32756167)

  • 1. Clinical efficacy of biomarkers for evaluation of volume status in dialysis patients.
    Park WY; Park S; Kim YW; Jin K
    Medicine (Baltimore); 2020 Jul; 99(31):e21460. PubMed ID: 32756167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients.
    Lee JA; Kim DH; Yoo SJ; Oh DJ; Yu SH; Kang ET
    Perit Dial Int; 2006; 26(3):360-5. PubMed ID: 16722030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.
    Madsen LH; Ladefoged S; Corell P; Schou M; Hildebrandt PR; Atar D
    Kidney Int; 2007 Mar; 71(6):548-54. PubMed ID: 17299526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between N-terminal pro-brain natriuretic peptide and fluid status in adverse clinical outcomes of late stages of chronic kidney disease.
    Tsai YC; Tsai HJ; Lee CS; Chiu YW; Kuo HT; Lee SC; Chen TH; Kuo MC
    PLoS One; 2018; 13(8):e0202733. PubMed ID: 30133531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modern peptide biomarkers and echocardiography in cardiac healthy haemodialysis patients.
    Rasche FM; Stoebe S; Ebert T; Feige S; Hagendorff A; Rasche WG; Barinka F; Busch V; Sack U; Schneider JG; Schiekofer S
    BMC Nephrol; 2017 May; 18(1):175. PubMed ID: 28558715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Terminal Prohormone of Brain Natriuretic Peptide but not C-Terminal Pre-Pro Vasopressin (Copeptin) Level is Associated with the Response to Antihypertensive Therapy in Haemodialysis Patients.
    Wyskida K; Ficek J; Ficek R; Adamska D; Jędrzejowska P; Wajda J; Klein D; Witkowicz J; Rotkegel S; Spiechowicz-Zatoń U; Kocemba-Dyczek J; Ciepał J; Więcek A; Olszanecka-Glinianowicz M; Chudek J
    Kidney Blood Press Res; 2017; 42(6):1013-1022. PubMed ID: 29190613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients: use of bioimpedance provides a different perspective from echocardiography and biomarker methodologies.
    Voroneanu L; Cusai C; Hogas S; Ardeleanu S; Onofriescu M; Nistor I; Prisada O; Sascau R; Goldsmith D; Covic A
    Int Urol Nephrol; 2010 Sep; 42(3):789-97. PubMed ID: 20521167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality.
    Pavo N; Raderer M; Hülsmann M; Neuhold S; Adlbrecht C; Strunk G; Goliasch G; Gisslinger H; Steger GG; Hejna M; Köstler W; Zöchbauer-Müller S; Marosi C; Kornek G; Auerbach L; Schneider S; Parschalk B; Scheithauer W; Pirker R; Drach J; Zielinski C; Pacher R
    Heart; 2015 Dec; 101(23):1874-80. PubMed ID: 26416836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and left atrial volume index to left ventricular function in chronic hemodialysis patients.
    Yamazaki M; Ogawa T; Tamei N; Ando Y; Nitta K
    Heart Vessels; 2011 Jul; 26(4):421-7. PubMed ID: 21127887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients.
    Paniagua R; Ventura MD; Avila-Díaz M; Hinojosa-Heredia H; Méndez-Durán A; Cueto-Manzano A; Cisneros A; Ramos A; Madonia-Juseino C; Belio-Caro F; García-Contreras F; Trinidad-Ramos P; Vázquez R; Ilabaca B; Alcántara G; Amato D
    Nephrol Dial Transplant; 2010 Feb; 25(2):551-7. PubMed ID: 19679559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.
    Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T
    Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients.
    Fahim MA; Hayen A; Horvath AR; Dimeski G; Coburn A; Johnson DW; Hawley CM; Campbell SB; Craig JC
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):620-9. PubMed ID: 25714960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-Term Influence of Radiofrequency Ablation on NT-proBNP, MR-proANP, Copeptin, and MR-proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study.
    Charitakis E; Walfridsson H; Alehagen U
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of malnutrition, N-terminal pro-B-type natriuretic peptide and ventricular remodeling in patients on maintenance hemodialysis.
    Lee YJ; Song BG; Kim MS; Cho S; Chun WJ; Oh JH; Kim SR
    Clin Nephrol; 2013 Apr; 79(4):253-60. PubMed ID: 23149248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between arterial stiffness and fluid status in peritoneal dialysis patients.
    Kocyigit I; Sipahioglu MH; Orscelik O; Unal A; Celik A; Abbas SR; Zhu F; Tokgoz B; Dogan A; Oymak O; Kotanko P; Levin NW
    Perit Dial Int; 2014; 34(7):781-90. PubMed ID: 24385328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between volume overload, chronic inflammation, and left ventricular dysfunction in chronic kidney disease patients.
    Hassan MO; Duarte R; Dix-Peek T; Vachiat A; Naidoo S; Dickens C; Grinter S; Manga P; Naicker S
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):131-135. PubMed ID: 27509588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Mortality in Chest Pain Patients: Comparison of Natriuretic Peptides With Novel Biomarkers of Cardiovascular Stress.
    Sinning C; Ojeda F; Zeller T; Zengin E; Rupprecht HJ; Lackner KJ; Bickel C; Blankenberg S; Schnabel RB; Westermann D
    Can J Cardiol; 2016 Dec; 32(12):1470-1477. PubMed ID: 27568502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.